Sofinnova Management Viii, L.l.c. - Net Worth and Insider Trading

Sofinnova Management Viii, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sofinnova Management Viii, L.l.c. owns 7 companies in total, including Principia Biopharma Inc (PRNB) , Aclaris Therapeutics Inc (ACRS) , and Synlogic Inc (SYBX) among others .

Click here to see the complete history of Sofinnova Management Viii, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Sofinnova Management Viii, L.l.c.

Ticker	Comapny	Transaction Date	Type of Owner
PRNB	Principia Biopharma Inc	2018-09-18	10 percent owner
ACRS	Aclaris Therapeutics Inc	2015-10-06	10 percent owner
SYBX	Synlogic Inc	2015-09-30	10 percent owner
		2015-01-29	10 percent owner
		2014-12-02	10 percent owner
		2014-09-11	10 percent owner
		2014-03-20	10 percent owner

Sofinnova Management Viii, L.l.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sofinnova Management Viii, L.l.c. Ownership Network

Ownership Network List of Sofinnova Management Viii, L.l.c.

No Data

Ownership Network Relation of Sofinnova Management Viii, L.l.c.

Sofinnova Management Viii, L.l.c. Owned Company Details

What does Principia Biopharma Inc do?

Who are the key executives at Principia Biopharma Inc?

Sofinnova Management Viii, L.l.c. is the 10 percent owner of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include director & President & CEO Martin Babler , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .

Principia Biopharma Inc (PRNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Principia Biopharma Inc Insider Transactions

No Available Data

What does Aclaris Therapeutics Inc do?

Who are the key executives at Aclaris Therapeutics Inc?

Sofinnova Management Viii, L.l.c. is the 10 percent owner of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .

Aclaris Therapeutics Inc (ACRS) Insider Trades Summary

Over the past 18 months, Sofinnova Management Viii, L.l.c. made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 14,705 shares made by James Loerop .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 2,697,852 shares, with a net purchase of 2,697,852 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,878,247 shares were bought by its insiders, resulting in a net purchase of 4,860,247 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aclaris Therapeutics Inc Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Sofinnova Management Viii, L.l.c. is the 10 percent owner of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Sofinnova Management Viii, L.l.c. made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 6,810 shares made by Antoine Awad , a net sale of 19,042 shares made by Aoife Brennan , and a net sale of 2,553 shares made by Michael Vangsted Jensen .

In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,429 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,429 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does Spark Therapeutics Inc do?

Who are the key executives at Spark Therapeutics Inc?

Sofinnova Management Viii, L.l.c. is the 10 percent owner of Spark Therapeutics Inc. Other key executives at Spark Therapeutics Inc include director & See Remarks Katherine A High , 10 percent owner Roche Holding Ltd , and director & CHIEF SCIENTIFIC OFFICER Lota S. Zoth .

Spark Therapeutics Inc (ONCE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Spark Therapeutics Inc (ONCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spark Therapeutics Inc (ONCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spark Therapeutics Inc (ONCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Spark Therapeutics Inc Insider Transactions

No Available Data

What does Ocugen Inc do?

Who are the key executives at Ocugen Inc?

Sofinnova Management Viii, L.l.c. is the 10 percent owner of Ocugen Inc. Other key executives at Ocugen Inc include CFO/CBO Quan Anh Vu , director & Chief Executive Officer Shankar Musunuri , and Chief Scientific Officer Arun Upadhyay .

Ocugen Inc (OCGN) Insider Trades Summary

Over the past 18 months, Sofinnova Management Viii, L.l.c. made no insider transaction in Ocugen Inc (OCGN). Other recent insider transactions involving Ocugen Inc (OCGN) include a net purchase of 200,278 shares made by Junge Zhang ,

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc (OCGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocugen Inc (OCGN) were sold and 200,278 shares were bought by its insiders, resulting in a net purchase of 200,278 shares.

Ocugen Inc (OCGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocugen Inc Insider Transactions

No Available Data

What does Alimera Sciences Inc do?

Who are the key executives at Alimera Sciences Inc?

Sofinnova Management Viii, L.l.c. is the 10 percent owner of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .

Alimera Sciences Inc (ALIM) Insider Trades Summary

Over the past 18 months, Sofinnova Management Viii, L.l.c. made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alimera Sciences Inc Insider Transactions

No Available Data

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

Sofinnova Management Viii, L.l.c. is the 10 percent owner of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc (ARAV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aravive Inc Insider Transactions

No Available Data

Sofinnova Management Viii, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Sofinnova Management Viii, L.l.c.. You might contact Sofinnova Management Viii, L.l.c. via mailing address: 3000 Sand Hill Road, 4-250, Menlo Park Ca 94025.

Discussions on Sofinnova Management Viii, L.l.c.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.